Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HOLOGIC INC | 815,306 | reported | 08 May 2014 | tx 141+2,848,154−2,745,485 |
| Neuronetics, Inc. | 401,816 | reported | 28 May 2026 | tx 19+417,930 |
| G1 Therapeutics, Inc. | 185,358 | reported | 18 Sept 2024 | tx 22+384,978−648,266 |
| Lifeward Ltd. | 4,176 | reported | 27 Jun 2017 | tx 2+8,352 |
| REPLIGEN CORP | 2,239 | reported | 14 May 2026 | tx 31+96,700−19,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Neuronetics, Inc. | 30,000 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | REPLIGEN CORP | 995 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | REPLIGEN CORP | 2,239 | 0.00 USD | deriv |
| 07 May 2026 | EXERCISE | REPLIGEN CORP | 2,434 | 38.76 USD | |
| 07 May 2026 | EXERCISE | REPLIGEN CORP | 2,434 | 0.00 USD | deriv |
| 16 Dec 2025 | EXERCISE | REPLIGEN CORP | 3,366 | 26.12 USD | |
| 16 Dec 2025 | EXERCISE | REPLIGEN CORP | 3,366 | 0.00 USD | deriv |
| 20 Oct 2025 | GRANT_AWARD | Neuronetics, Inc. | 7,554 | 0.00 USD | |
| 22 May 2025 | GRANT_AWARD | Neuronetics, Inc. | 30,000 | — | |
| 15 May 2025 | GRANT_AWARD | REPLIGEN CORP | 973 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | REPLIGEN CORP | 1,800 | 0.00 USD | deriv |
| 07 Feb 2025 | OTHER | Neuronetics, Inc. | 44,444 | 2.25 USD | |
| 19 Nov 2024 | EXERCISE | REPLIGEN CORP | 19,000 | 36.29 USD | |
| 19 Nov 2024 | EXERCISE | REPLIGEN CORP | 19,000 | 0.00 USD | deriv |
| 18 Sept 2024 | OTHER | G1 Therapeutics, Inc. | 20,000 | — | |
| 18 Sept 2024 | TENDER | G1 Therapeutics, Inc. | 185,358 | — | |
| 18 Sept 2024 | OTHER | G1 Therapeutics, Inc. | 30,000 | — | deriv |
| 18 Sept 2024 | OTHER | G1 Therapeutics, Inc. | 50,000 | — | deriv |
| 18 Sept 2024 | OTHER | G1 Therapeutics, Inc. | 30,000 | — | deriv |
| 18 Sept 2024 | OTHER | G1 Therapeutics, Inc. | 30,000 | — | deriv |
| 05 Sept 2024 | PURCHASE | Neuronetics, Inc. | 25,000 | 0.80 USD | |
| 29 Aug 2024 | PURCHASE | Neuronetics, Inc. | 12,224 | 0.85 USD | |
| 28 Aug 2024 | PURCHASE | Neuronetics, Inc. | 12,776 | 0.85 USD | |
| 20 Aug 2024 | PURCHASE | Neuronetics, Inc. | 25,000 | 1.00 USD | |
| 14 Aug 2024 | PURCHASE | Neuronetics, Inc. | 25,171 | 0.75 USD | first after silence |
4 purchases reported after at least 12 months of silence — most recent on 14 Aug 2024.